BE678208A - - Google Patents

Info

Publication number: BE678208A
Authority: BE; Belgium

Application number

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1965-04-30

Filing date

1966-03-22

Publication date

1966-09-01

1966-03-22 Application filed filed Critical

1966-09-01 Publication of BE678208A publication Critical patent/BE678208A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BE678208D 1965-04-30 1966-03-22 BE678208A (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE571165		1965-04-30
US55822666A	1966-06-17	1966-06-17

Publications (1)

Publication Number	Publication Date
BE678208A true BE678208A (fr)	1966-09-01

Family

ID=26654650

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BE678208D BE678208A (fr)	1965-04-30	1966-03-22

Country Status (11)

Country	Link
US (3)	US3466325A (fr)
JP (3)	JPS50653B1 (fr)
BE (1)	BE678208A (fr)
BR (1)	BR6678981D0 (fr)
CH (1)	CH484053A (fr)
DE (1)	DE1294955B (fr)
FI (2)	FI42955B (fr)
FR (1)	FR5745M (fr)
GB (2)	GB1140508A (fr)
NL (1)	NL143550B (fr)
NO (1)	NO115797B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3969512A (en) *	1935-11-15	1976-07-13	Boehringer Ingelheim Gmbh	N,N'bis-(3-phenoxy-2-hydroxy-propyl)-alkylenediamines and salts thereof
SE354851B (fr) *	1970-02-18	1973-03-26	Haessle Ab
US3959486A (en) *	1970-05-27	1976-05-25	Imperial Chemical Industries Limited	Method for producing β-adrenergic blockage with alkanolamine derivatives
US4059622A (en) *	1970-05-27	1977-11-22	Imperial Chemical Industries Limited	Alkanolamine derivatives
SE386892B (sv) *	1972-07-06	1976-08-23	Haessle Ab	Forfarande for framstellning av oxaminoforeningar
US4018825A (en) *	1972-07-27	1977-04-19	Warner-Lambert Company	5-Hydroxy-α-(substituted aminomethyl)-m-xylene-α,α'-diols
US4067904A (en) *	1975-12-19	1978-01-10	Mead Johnson & Company	Alkylsulfonylphenoxypropanolamine derivatives
US4119729A (en) *	1975-12-19	1978-10-10	Mead Johnson & Company	Alkylsulfonylphenoxypropanolamine therapeutic process
US4243681A (en) *	1977-10-11	1981-01-06	Mead Johnson & Company	Alkylthiophenoxypropanolamines and pharmaceutical compositions and uses thereof
EP0013258B1 (fr) *	1978-12-29	1982-07-07	Ciba-Geigy Ag	Phénolglycidyl éthers substitués par des groupes propényle, procédé pour leur préparation et leur application
US4945182A (en) *	1985-12-24	1990-07-31	Merck & Co., Inc.	Oculoselective beta-blockers
US5254595A (en) *	1988-12-23	1993-10-19	Elf Sanofi	Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them
JP2780559B2 (ja) *	1991-01-25	1998-07-30	信越化学工業株式会社	アリル基又はプロペニル基を持つナフタレン誘導体
CA2134038C (fr) *	1994-06-16	1997-06-03	David Taiwai Wong	Potentialisation des effets de medicaments
EP0714663A3 (fr)	1994-11-28	1997-01-15	Lilly Co Eli	Potentialisation d'un médicament par un antagoniste du récepteur sérotonine 1A
ES2145977T3 (es) *	1995-08-16	2000-07-16	Lilly Co Eli	Potenciacion de la respuesta de la serotonina.
US7034059B2 (en) *	2001-07-02	2006-04-25	Sepracor Inc.	Methods of using norfluoxetine
US20030087963A1 (en)	2001-09-13	2003-05-08	Senanayake Chris H.	Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
OA12905A (en)	2002-08-19	2006-10-13	Pfizer Prod Inc	Combination therapy for hyperproliferative diseases.
US20060063803A1 (en) *	2004-09-23	2006-03-23	Pfizer Inc	4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
GT200600381A (es)	2005-08-25	2007-03-28		Compuestos organicos
US7741317B2 (en)	2005-10-21	2010-06-22	Bristol-Myers Squibb Company	LXR modulators
US7888376B2 (en)	2005-11-23	2011-02-15	Bristol-Myers Squibb Company	Heterocyclic CETP inhibitors
WO2008070496A2 (fr)	2006-12-01	2008-06-12	Bristol-Myers Squibb Company	Inhibiteurs d'amino cetp étendus
US20100120694A1 (en)	2008-06-04	2010-05-13	Synergy Pharmaceuticals, Inc.	Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US8969514B2 (en)	2007-06-04	2015-03-03	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US7879802B2 (en)	2007-06-04	2011-02-01	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8987262B2 (en)	2007-10-19	2015-03-24	Universite de Bordeaux	Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
EP2050441A1 (fr)	2007-10-19	2009-04-22	Université Victor Segalen Bordeaux 2	Utilisation de bêtabloquants pour la fabrication d'un médicament pour le traitement d'hémangiomes
ES2624828T3 (es)	2008-07-16	2017-07-17	Synergy Pharmaceuticals Inc.	Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en)	2010-09-15	2017-04-11	Synergy Pharmaceuticals, Inc.	Formulations of guanylate cyclase C agonists and methods of use
CA2905438A1 (fr)	2013-03-15	2014-09-25	Synergy Pharmaceuticals Inc.	Agonistes de la guanylate cyclase et leurs utilisations
AU2014235209B2 (en)	2013-03-15	2018-06-14	Bausch Health Ireland Limited	Guanylate cyclase receptor agonists combined with other drugs
RU2618628C1 (ru)	2013-04-17	2017-05-05	Пфайзер Инк.	Производные N-пиперидин-3-илбензамида для лечения сердечно-сосудистых заболеваний
EP3004138B1 (fr)	2013-06-05	2024-03-13	Bausch Health Ireland Limited	Agonistes ultra-purs de guanylate cyclase c, leur procédé de production et d'utilisation
EP2959904A1 (fr)	2014-06-27	2015-12-30	Institut De Recerca Contra La Leucemia Josep Carreras	Procédés pour traiter, diagnostiquer et pronostiquer une tumeur maligne hématologique
WO2016055901A1 (fr)	2014-10-08	2016-04-14	Pfizer Inc.	Composés d'amide substitué
FR3030514A1 (fr) *	2014-12-18	2016-06-24	Centre De Coop Int En Rech Agronomique Pour Le Dev (Cirad)	Dimeres polyaromatiques

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2967201A (en) *	1958-06-02	1961-01-03	Lilly Co Eli	Alkylaminoalkyl ethers of phenols
NL300886A (fr) *	1962-11-23
NL301580A (fr) *	1962-12-11
GB1069345A (en) *	1963-07-19	1967-05-17	Ici Ltd	New alkanolamine derivatives
NL131194C (fr) *	1963-07-19
DE1493454C3 (de) *	1963-08-26	1980-04-30	C.H. Boehringer Sohn, 6507 Ingelheim	1 -Aryloxy^-hydroxy-S-isopropylaminopropane und deren Salze sowie deren Herstellung und darauf basierende Arzneimittel
CH455834A (de) *	1964-10-14	1968-05-15	Ciba Geigy	Verfahren zur Herstellung des neuen 1-Isopropylamino-2-hydroxy-3-(2'-isopropoxy-phenoxy)-propans oder seinen Salzen

1966
- 1966-01-18 US US521436A patent/US3466325A/en not_active Expired - Lifetime
- 1966-01-26 GB GB3531/66A patent/GB1140508A/en not_active Expired
- 1966-01-26 GB GB40546/68A patent/GB1140860A/en not_active Expired
- 1966-01-28 JP JP41004651A patent/JPS50653B1/ja active Pending
- 1966-01-29 DE DEA51453A patent/DE1294955B/de active Pending
- 1966-03-22 BE BE678208D patent/BE678208A/xx not_active IP Right Cessation
- 1966-03-31 CH CH469666A patent/CH484053A/de not_active IP Right Cessation
- 1966-04-05 NO NO162482A patent/NO115797B/no unknown
- 1966-04-26 BR BR178981/66A patent/BR6678981D0/pt unknown
- 1966-04-26 FI FI1089/66A patent/FI42955B/fi active
- 1966-04-27 FR FR59328A patent/FR5745M/fr not_active Expired
- 1966-04-28 NL NL666605692A patent/NL143550B/xx not_active IP Right Cessation
- 1966-06-17 US US558226A patent/US3466376A/en not_active Expired - Lifetime
1969
- 1969-08-15 US US872789*A patent/US3631108A/en not_active Expired - Lifetime
1970
- 1970-04-03 FI FI0931/70A patent/FI44392B/fi active
- 1970-12-28 JP JP45120574A patent/JPS4929182B1/ja active Pending
1972
- 1972-12-14 JP JP47124826A patent/JPS4930819B1/ja active Pending

Also Published As

Publication number	Publication date
GB1140860A (en)	1969-01-22
NO115797B (fr)	1968-12-09
CH484053A (de)	1970-01-15
GB1140508A (en)	1969-01-22
BR6678981D0 (pt)	1973-09-18
US3466376A (en)	1969-09-09
US3631108A (en)	1971-12-28
US3466325A (en)	1969-09-09
FI44392B (fr)	1971-08-02
FI42955B (fr)	1970-09-02
DE1294955B (de)	1969-05-14
JPS50653B1 (fr)	1975-01-10
NL6605692A (fr)	1966-10-31
NL143550B (nl)	1974-10-15
JPS4930819B1 (fr)	1974-08-16
JPS4929182B1 (fr)	1974-08-01
FR5745M (fr)	1968-01-29

Publication	Publication Date	Title
FI44392B (fr)	1971-08-02
FR5149M (fr)	1967-06-12
BE658161A (fr)	1965-04-30
BE659951A (fr)	1965-06-16
BE661304A (fr)
BE661729A (fr)	1965-07-16
BE662523A (fr)	1965-08-02
BE663662A (fr)	1965-09-01
BE664767A (fr)	1965-12-01
BE665237A (fr)	1965-12-10
BE666367A (fr)	1965-11-03
BE667030A (fr)	1965-11-16
BE668354A (fr)	1965-12-16
BE668772A (fr)	1966-02-25
BE669450A (fr)	1965-12-31
BE669732A (fr)	1966-01-17
BE669937A (fr)	1966-01-17
BE669966A (fr)	1966-01-17
BE670151A (fr)	1966-01-17
BE670715A (fr)	1966-01-31
BE671411A (fr)
BE672472A (fr)	1966-05-17
BE672522A (fr)	1966-03-16
BE672643A (fr)	1966-03-16
BE673529A (fr)	1966-04-01

Legal Events

Date	Code	Title	Description
1986-01-01	RE20	Patent expired	Owner name: A.B. HASSLE APOTEKARE PAUL NORDSTROMS FABRIKER Effective date: 19860322

Date

Code

Title

Description

1986-01-01

RE20

Patent expired

Owner name: A.B. HASSLE APOTEKARE PAUL NORDSTROMS FABRIKER

Effective date: 19860322